BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 15507275)

  • 1. How much warfarin is enough in APS related thrombosis?
    Erkan D; Lockshin MD
    Thromb Res; 2004; 114(5-6):435-42. PubMed ID: 15507275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current management of antiphospholipid syndrome-related thrombosis.
    Puente D; Pombo G; Forastiero R
    Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1551-8. PubMed ID: 19954317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence based treatment of the antiphospholipid syndrome II. Optimal anticoagulant therapy for thrombosis.
    Crowther MA; Wisloff F
    Thromb Res; 2005; 115(1-2):3-8. PubMed ID: 15567446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.
    Crowther MA; Ginsberg JS; Julian J; Denburg J; Hirsh J; Douketis J; Laskin C; Fortin P; Anderson D; Kearon C; Clarke A; Geerts W; Forgie M; Green D; Costantini L; Yacura W; Wilson S; Gent M; Kovacs MJ
    N Engl J Med; 2003 Sep; 349(12):1133-8. PubMed ID: 13679527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibodies in critical illness.
    Dentali F; Crowther M
    Crit Care Med; 2010 Feb; 38(2 Suppl):S51-6. PubMed ID: 20083914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards evidence-based treatment of thrombotic antiphospholipid syndrome.
    Derksen RH; de Groot PG
    Lupus; 2010 Apr; 19(4):470-4. PubMed ID: 20353990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of antiphospholipid syndrome.
    Tuthill JI; Khamashta MA
    J Autoimmun; 2009 Sep; 33(2):92-8. PubMed ID: 19559568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical manifestations and outcomes of antithrombotic treatment of the Tan Tock Seng Hospital Singapore antiphospholipid syndrome cohort.
    Tan BE; Thong BY; Shivananda S; Han WW; Chng HH
    Lupus; 2009 Jul; 18(8):752-8. PubMed ID: 19502274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of thrombosis in the antiphospholipid-antibody syndrome.
    Khamashta MA; Cuadrado MJ; Mujic F; Taub NA; Hunt BJ; Hughes GR
    N Engl J Med; 1995 Apr; 332(15):993-7. PubMed ID: 7885428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis.
    Krnic-Barrie S; O'Connor CR; Looney SW; Pierangeli SS; Harris EN
    Arch Intern Med; 1997 Oct; 157(18):2101-8. PubMed ID: 9382667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longterm anticoagulation is preferable for patients with antiphospholipid antibody syndrome. result of a decision analysis.
    Brunner HI; Chan WS; Ginsberg JS; Feldman BM
    J Rheumatol; 2002 Mar; 29(3):490-501. PubMed ID: 11908562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Warfarin in the treatment of antiphospholipid syndrome].
    Reshetniak TM; Kondrat'eva LV; Patrusheva NL; Patrushev LI
    Ter Arkh; 2007; 79(5):47-54. PubMed ID: 17672075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thrombosis in the antiphospholipid syndrome.
    Farmer-Boatwright MK; Roubey RA
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid syndrome.
    Erkan D; Lockshin MD
    Curr Opin Rheumatol; 2006 May; 18(3):242-8. PubMed ID: 16582686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid antibody syndrome.
    Saigal R; Kansal A; Mittal M; Singh Y; Ram H
    J Assoc Physicians India; 2010 Mar; 58():176-84. PubMed ID: 20848817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?
    Pierangeli SS; Erkan D
    Lupus; 2010 Apr; 19(4):475-85. PubMed ID: 20353991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of antiphospholipid antibody syndrome: a systematic review.
    Lim W; Crowther MA; Eikelboom JW
    JAMA; 2006 Mar; 295(9):1050-7. PubMed ID: 16507806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity and duration of anticoagulation therapy in antiphospholipid syndrome.
    Les I; Ruiz-Irastorza G; Khamashta MA
    Semin Thromb Hemost; 2012 Jun; 38(4):339-47. PubMed ID: 22467528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on antiphospholipid syndrome.
    Lockshin MD
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):57-9. PubMed ID: 17121491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point-of-care testing of the international normalized ratio in patients with antiphospholipid antibodies.
    Perry SL; Samsa GP; Ortel TL
    Thromb Haemost; 2005 Dec; 94(6):1196-202. PubMed ID: 16411394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.